Life Sciences - A Burgeoning Real Estate Asset Class

Published date05 May 2021
Subject MatterLife Sciences,Startups,Real Estate Market,Clinical Laboratories,Real Estate Investments,Commercial Real Estate Market,Early Stage Companies,Pharmaceutical Industry,Coronavirus/COVID-19
AuthorVictoria Landsbert
Law FirmWhite & Case LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT